Our results contrast with studies that showed reduced expression and function of ABCG1 (but not ABCA1) in monocytes and macrophages in people with T2DM [27], [28], but these earlier studies were not designed or conducted in drug naive patients who were free of complications. This evidence concerns the gene ABCA1 and type 2 diabetes mellitus.